Journal Articles

Landmark EVRA trial: the evidence for interventional venous leg ulcer management

Share this article

Landmark EVRA trial: the evidence for interventional venous leg ulcer management

Alan Elstone
28 June 2018

The results of the Early Venous Reflux Ablation (EVRA) trial were presented last month in London (Gohel et al, 2018). The ​world of venous leg ulcer (VLU) management has finally gained significant Level 1 evidence with the potential to change future practice. EVRA’s primary outcome was to research the effects of venous intervention on ulcer healing. The main conclusions were that early venous ablation of superficial venous reflux resulted in faster healing of VLUs, increased time free from ulceration and significant cost savings. These are important outcomes for patients, healthcare professionals and commissioners.

Free for all healthcare professionals

Sign up to the Wounds Group journals





By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.